Use of Commercial Claims Data for Evaluating Trends in Lyme Disease Diagnoses, United States, 2010–2018

Use of Commercial Claims Data for Evaluating Trends in Lyme Disease Diagnoses, United States, 2010–2018

We evaluated MarketScan, a large commercial insurance claims database, for its potential use as a stable and consistent source of information on Lyme disease diagnoses in the United States. The age, sex, and geographic composition of the enrolled population during 2010–2018 remained proportionally...

Full description

Bibliographic Details
Main Authors: Amy M. Schwartz, Kiersten J. Kugeler, Christina A. Nelson, Grace E. Marx, Alison F. Hinckley
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2021-02-01
Series:Emerging Infectious Diseases
Subjects:
Lyme disease
public health surveillance
incidence
vector-borne infections
zoonoses
United States
Online Access:https://wwwnc.cdc.gov/eid/article/27/2/20-2728_article

Internet

https://wwwnc.cdc.gov/eid/article/27/2/20-2728_article

Similar Items